DCGI approves Corbevax as 1st heterologous COVID-19 booster shot

Search

DCGI approves Corbevax as 1st heterologous COVID-19 booster shot

"The Corbevax heterologous booster vaccine was well tolerated and safe. There were no severe or adverse events of interest for 3 months of follow-up after the booster dose was administered," said the statement.